Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
4.090
+0.170 (4.34%)
May 18, 2026, 4:00 PM EDT - Market closed
Evaxion Market Cap
Evaxion has a market cap or net worth of $34.11 million as of May 19, 2026. Its market cap has increased by 243.97% in one year.
Market Cap
34.11M
Enterprise Value
15.67M
1-Year Change
243.97%
Ranking
Category
Stock Price
$4.09
Market Cap Chart
Since the IPO on February 5, 2021, Evaxion's market cap has decreased from $191.99M to $34.11M, a decrease of -82.23%. That is a compound annual growth rate of -27.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 34.11M | -14.26% |
| Dec 31, 2025 | 39.78M | 702.21% |
| Dec 31, 2024 | 4.96M | -80.92% |
| Dec 29, 2023 | 25.99M | -39.34% |
| Dec 30, 2022 | 42.84M | -58.12% |
| Dec 31, 2021 | 102.29M | -46.72% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NextCure | 35.14M |
| Pluri | 33.87M |
| Veru Inc. | 33.87M |
| Boundless Bio | 33.58M |
| Grace Therapeutics | 33.42M |
| Tevogen Bio Holdings | 33.29M |
| Apollomics | 32.94M |
| NanoViricides | 31.96M |